Skip to main content

Table 3 Plasma levels of serine protease inhibitors in asymptomatic and COPD subjects independent of genetic variant of AAT

From: Plasma levels of alpha1-antichymotrypsin and secretory leukocyte proteinase inhibitor in healthy and chronic obstructive pulmonary disease (COPD) subjects with and without severe α1-antitrypsin deficiency

Subjects

N

ACT (mg/ml)

N

SLPI (ng/ml)

  

Mean* ± SD

 

Mean* ± SD

Healthy

153

0.40 ± 0.10

153

40.7 ± 9.1

COPD

19

0.52 ± 0.19

20

49.5 ± 7.2

  1. *) geometric mean
  2. SD, standard deviation
  3. N-number of subjects